TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study.

John F R Robertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.